(Q68308063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

A little more information about aggravation of probucol-induced HDL-reduction by clofibrate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

23 September 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

30 December 2022

author name string

S. Yokoyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3355613

30 December 2022

A. Yamamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3355613

30 December 2022

T. Kurasawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3355613

30 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3355613

30 December 2022

publication date

1 March 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:0021915088901141?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

https://api.elsevier.com/content/article/PII:0021915088901141?httpAccept=text/plain

30 December 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

30 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

179-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

Effects of probucol on homozygous cases of familial hypercholesterolemia

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

Effects of probucol on xanthomata regression in familial hypercholesterolemia

30 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

30 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

Probucol prevents lipid storage in macrophages

30 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

Medical management of hyperlipidemia and the role of probucol

30 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0021-9150(88)90114-1

30 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3355613%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference